Argenx
ARGX
#454
Rank
C$71.57 B
Marketcap
C$1,149
Share price
-0.58%
Change (1 day)
28.70%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - P/B ratio

P/B ratio as of December 2025 : 8.63

According to Argenx 's latest financial reports the company has a price-to-book ratio of 14.5999.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Argenx - P/B ratio (from 2019 to 2020)

P/B ratio by year

Year P/B ratio Change
2025-12-318.6326.73%
2024-12-316.8123.68%
2023-12-315.51-26.06%
2022-12-317.452.64%
2021-12-317.26-13.36%
2020-12-318.3843.74%
2019-12-315.8317.1%
2018-12-314.9823.24%
2017-12-314.04
2016-12-31N/A
2015-12-31N/A-100%
2014-12-311.96
2013-12-31N/A